<DOC>
	<DOCNO>NCT00524823</DOCNO>
	<brief_summary>Early detection prostrate cancer development metastasis . The research attempt match SCM test ( structuredness cytoplasmic matrix ) lymphocytes early cancer detection test use Florescent Activated Cell Sorting ( FACS ) replacement CellScan instrument . The test base measurement cellular change response specific prostate antigen , PSA .</brief_summary>
	<brief_title>Early Detection Prostate Cancer FACS</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<criteria>Experimental group : Males age 6090 year , medical diagnosis prostate cancer accord clinical hematological examination , receive medical treatment . Control Group 1 : Males age 6090 year , diagnose benign prostate hyperplasia BPH . Control Group 2 : Males age 6090 year , medically diagnose healthy . Control Group 3 : Males age 6090 year , medically diagnose another form cancer , prostate . Experimental group : Other known cancer systemic infection . Control Group 1 : Other known cancer systemic infection . Control Group 2 : Past hematological disorder cancer growth history . know systemic infection , urinary tract infection . Patients hospitalize orthopedic injury type otherwise free urinary tract infection . Control Group 3 : Other know systemic infection , urinary tract infection .</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Hyperplasia - BPH</keyword>
	<keyword>FACS</keyword>
	<keyword>Prostate Cancer , Hyperplasia - BPH , Malignancy</keyword>
</DOC>